According to a new market research study titled ‘Transplant Diagnostics Market to 2027 – Global Analysis and Forecasts by Product & Services, Type, Technology, Application, and End User’. The global transplant diagnostics market is expected to reach US$ 1,542.89 Mn in 2027 from US$ 789.88 Mn in 2018. The market is estimated to grow with a CAGR of 7.9% from 2019-2027. The report highlights the trends prevalent in the global transplant diagnostics market and the factors driving the market along with those that act as deterrents to its growth.

Transplant diagnostics refers to the diagnostics tests that are conducted on the organs that are meant to be transplanted. These tests are either conducted pre transplantation as well as post transplantation. Some of the common techniques used in transplant diagnostics include, sequence based molecular assays, PCR based molecular assays and also non-molecular assays in certain cases. Transplant diagnostics is an essential factor in organ transplantation as it avoids any further complications that could occur after a transplant procedures

Global transplant diagnostics market, based on application was segmented as, diagnostic applications and research applications. In 2018, diagnostic applications segment held the largest share of the market, by application. Moreover, the segment is expected to grow at the fastest rate during the coming years owing to the prevalence of infectious as well as chronic diseases, leading to the demand for an organ transplant.

The major players operating in the transplant diagnostics market are, Thermo Fisher Scientific Inc., Abbott, Illumina, Inc., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., bioMérieux SA, QIAGEN, Hologic Inc., Luminex Corporation, and Omixon Inc. Inorganic activities such as, partnership is a prominent parameter undertaken by industry players. For instance, in May, 2018, Omixon entered into a partnership with Dilen s.r.o. As part of the partnership, Dilen has been appointed as the exclusive distributor in Kazakhstan. The developments performed by the companies are helping the market to grow in the coming years.

The report segments the global transplant diagnostics market as follows:

Global Transplant Diagnostics Market – By Product & Services

• Instruments
• Reagents & Consumables
• Software & Services

Global Transplant Diagnostics Market – By Type

• Solid Organ Transplantation
• Lung Transplantation
• Liver Transplantation
• Kidney Transplantation
• Heart Transplantation
• Other Solid Organ Transplantations
• Soft Tissue Transplantation
• Stem Cell Transplantation

Global Transplant Diagnostics Market – By Technology

• Molecular Assays
• Sequencing-Based Molecular Assays
• Next-Generation Sequencing
• Sanger Sequencing
• Other Sequencing-Based Molecular Assays
• PCR-Based Molecular Assays
• Real-Time PCR
• Sequence-Specific Primer-PCR
• Other PCR-Based Molecular Assays
• Non-Molecular Assays

Global Transplant Diagnostics Market – By Application

• Diagnostic Applications
• Pre-Transplantation Diagnostics
• Post-Transplantation Diagnostics
• Research Applications

Global Transplant Diagnostics Market – By End User

• Hospitals & Transplant Centers
• Research Laboratories & Academic Institutes
• Independent Reference Laboratories

Global Transplant Diagnostics Market – By Geography

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • U.K
  • Spain
  • Italy
• Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Middle East & Africa (MEA)
  • Saudi Arabia
  • U.A.E
  • South Africa
• South & Central America (SCAM)
  • Brazil
  • Argentina

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com